Geographic atrophy
Similarities and Differences Between Pachychoroid GA and Conventional GA Identified
Understanding these features may help disease diagnosis in Asian populations. Patients with the former subtype were significantly younger, predominantly male and had a slower progression rate.
04/12/2024
Study Finds Imaging Biomarkers Associated with GA Growth Rate
Progression is positively associated with non-exudative subretinal fluid and hyperreflective material as well as iRORA. It’s negatively associated with retinal pseudocysts and subfoveal choroid thickness.
04/01/2024
Pachydrusen in AMD Eyes Raises Risk of MNV but Not GA
This is especially the case when macular pigmentary changes are also present, study finds.
03/20/2024
Investigative GA Drug Fares Poorly in Phase II Trial
After 24 months of treatment with oral minocycline, participants showed no significant decrease in lesion enlargement rate. Mild and moderate AEs were also common.
03/19/2024
Investigational Subretinal Implant Could Help Restore Vision Loss from GA
Device seeks to mimic photoreceptor function and re-enable retinal neurons. Three subjects gained at least four ETDRS lines in recent tests.
03/12/2024
Thin Double Layer Sign in the Fovea on OCT Predicts GA
Structural imaging shows the presence of biomarkers associated with the development of foveal atrophy at two years.
02/14/2024
AMD Genetic Profile Predictive of Early GA Enlargement
ARMS2/HTRA1 is an important risk factor for identifying eyes likely to experience fast lesion progression.
09/19/2023
New GA Drug from Iveric Bio Approved
Clinical trials show Izervay can slow disease progression with as few as six monthly doses.
08/07/2023
Novel Microperimetry Endpoints Better at Detecting Functional Decline in GA
The metrics could lead to future clinical trials that better characterize both the natural history of the disease as well as early treatment response, the authors suggest.
06/16/2023
The World According to GARPED
Study finds GA patients with a reabsorbed PED have significant visual deficits and may not benefit from new treatments aimed at inhibiting the complement system, as the mechanism is different.
06/01/2023
Upcoming Events
May 2, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Kamran Riaz, MD, and Melissa Barnett, OD
Webinar: 7:00pm ET
Sponsored by Bausch + Lomb
May 17-19, 2024
June 4, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Karl G. Stonecipher, MD, and Jessica Steen, OD
Webinar: 8:00pm ET
Sponsored by Bausch + Lomb
